title: ATP-induced inhibition of gap junctional communication is enhanced by interleukin-1 beta treatment in cultured astrocytes.
abstract: Nucleotides are signaling molecules involved in variety of interactions between neurons, between glial cells as well as between neurons and glial cells. In addition, ATP and other nucleotides are massively released following brain insults, including inflammation, and may thereby be involved in mechanisms of cerebral injury. Recent concepts have shown that in astrocytes intercellular communication through gap junctions may play an important role in neuroprotection. Therefore, we have studied the effects of nucleotides on gap junction communication in astrocytes. Based on measurement of intercellular dye coupling and recording of junctional currents, the present study shows that ATP (10-100 microM) induces a rapid and a concentration-dependent inhibition of gap junction communication in cultured cortical astrocytes from newborn mice. Effects of agonists and antagonists of purinergic receptors indicate that the inhibition of gap junctional communication by ATP mainly involves the stimulation of metabotropic purinergic 1 (P2Y(1)) receptors. Pretreatment with the pro-inflammatory cytokine interleukin-1beta (10 ng/ml, 24 h), which has no effect by itself on gap junctional communication, increases the inhibitory effect of ATP and astrocytes become sensitive to uridine 5'-triphosphate (UTP). As indicated by the enhanced expression of P2Y(2) receptor mRNA, P2Y(2) receptors are responsible for the increased responses evoked by ATP and UTP in interleukin-1beta-treated cells. In addition, the effect of endothelin-1, a well-known inhibitor of gap junctional communication in astrocytes was also exacerbated following interleukin-1beta treatment. We conclude that ATP decreases intercellular communication through gap junctions in astrocytes and that the increased sensitivity of gap junction channels to nucleotides and endothelin-1 is a characteristic feature of astrocytes exposed to pro-inflammatory treatments.
authors.affiliation: INSERM U114, Collège de France, 11 Place Marcelin Berthelot, 75231 Paris, Cedex 05, France.
authors.forename: W
authors.initials: W
authors.lastname: Même
authors.forename: P
authors.initials: P
authors.lastname: Ezan
authors.forename: L
authors.initials: L
authors.lastname: Venance
authors.forename: J
authors.initials: J
authors.lastname: Glowinski
authors.forename: C
authors.initials: C
authors.lastname: Giaume
mesh_terms: D000244:Adenosine Diphosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D002450:Cell Communication / Q000187:drug effects* / Q000502:physiology; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology; D018031:Connexin 43 / Q000378:metabolism; D003342:Corpus Striatum / Q000166:cytology; D004357:Drug Synergism; D004553:Electric Conductivity; D019332:Endothelin-1 / Q000494:pharmacology; D017629:Gap Junctions / Q000502:physiology*; D007375:Interleukin-1 / Q000494:pharmacology*; D051379:Mice; D051381:Rats; D014544:Uridine Triphosphate / Q000494:pharmacology
chemical_list: D018031:Connexin 43; D019332:Endothelin-1; D007375:Interleukin-1; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D014544:Uridine Triphosphate